A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery

Journal of Liposome Research

Volumn 22, Issue 2, 2012, Pages 128-138

  Yehia, Soad A ^a   Elshafeey, Ahmed H ^a   Elsayed, Ibrahim ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Burst release; in situ implant; Injectable; Lipospheres; PDLG

Indexed keywords

1 METHYL 2 PYRROLIDINONE; DONEPEZIL; DRUG CARRIER; GLYCEROL STEARATE; HEXADECANOL; LIPOSPHERE; POLYGLACTIN; POLYLACTIDE; TRIACETIN; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; IMPLANT; MOLECULAR WEIGHT; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; VISCOSITY;

DRUG DELIVERY SYSTEMS; INDANS; LACTIC ACID; LIPOSOMES; PIPERIDINES; POLYESTERS; POLYGLYCOLIC ACID;

EID: 84862061701     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2011.631141     Document Type: Article

References (58)

1. Ahmed, A. R., Dashevsky, A., Bodmeier, R. (2008). Reduction in burst release of PLGA microparticles by incorporation intocubic phase-forming systems. Eur J Pharm Biopharm 70: 765-769.
2. Barakat, N. S., Yassin, A. E. (2006). In vitro characterization of carbamazepine-loaded precifac lipospheres. Drug Deliv 13: 95-104. (Pubitemid 43162305)
3. Barnes, H. A., Hutton, J. E., Walters, K. (1993). An introduction to rheology. Amsterdam: Elsevier.
4. Bernkop-Schnurch, A., Hornof, M., Zoidl, T. (2003). Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm 260: 229-237. (Pubitemid 36773920)
5. Blanco, D., Alonso, M. J. (1998). Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm 45: 285-294. (Pubitemid 28270817)
6. Boylan, J. C., Nail, S. L. (2009). Parenteral products. In: Florence, A. T., Siepmann, J. (Eds.), Modern pharmaceutics: basic principles and systems, 5th ed. (pp. 565-609). New York: Informa.
7. Brodbeck, K. J., DesNoyer, J. R., McHugh, A. J. (1999). Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J Control Release 62: 333-344. (Pubitemid 29476581)
8. Brookfield. (2010). Laboratory viscometer application data sheet. Brookfield Engineering Laboratories. Available at: http://www. brookfieldengineering.com/education/applications/laboratory-dishwasher- detergent.asp. Accessed on April 2,2011.
9. Carrasquillo, K. G., Stanley, A. M., Aponte-Carro, J. C., De Jesus, P., Costantino, H. R., Bosques, C. J., et al. (2001). Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J Control Release 76: 199-208. (Pubitemid 32913430)
10. Chitkara, D., Shikanov, A., Kumar, N., Domb, A. J. (2006). Biodegradable injectable in situ depot-forming drug delivery systems. Macromol Biosci 6: 977-990. (Pubitemid 46032935)
11. Cho, K. Y., Lee, S., Park, J. K. (2007). In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer. Macromol Biosci 7: 784-788. (Pubitemid 47237505)
12. Cortesi, R., Esposjto, E., Luca, G., Nastruzzi, C. (2002). Production of lipospheres as carriers for bioactive compounds. Biomaterials 23: 2283-2294. (Pubitemid 34234829)
13. Cui, F., Cun, D., Tao, A., Yang, M., Shi, K., Zhao, M., et al. (2005). Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method. J Control Release 107: 310-319. (Pubitemid 41316293)
14. DesNoyer, J. R., McHugh, A. J. (2003). The effect of Pluronic on the protein release kinetics of an injectable drug delivery system. J Control Release 86: 15-24. (Pubitemid 35461971)
15. Dunn, R. L., English, J. P., Cowsar, D. R., Vanderbilt, D. P. (1990). Biodegradable in situ forming implants and methods of producing the same. US Patent 4938763.
16. Esposito, E., Cortesi, R., Nastruzzi, C. (2005). Production of lipospheres for bioactive compound delivery. In: Nastruzzi, C. (Ed.), Lipospheres in drug targets and delivery: approaches, methods, and applications (pp. 23-40). Boca Raton, Florida, USA: CRC.
17. Gad, H. A., El-Nabarawi, M. A., Abd El-Hady, S. S. (2008). Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis. AAPS PharmSciTech 9: 878-884.
18. Graham, P. D., Brodbeck, K. J., McHugh, A. J. (1999). Phase inversion dynamics of PLGA solutions related to drug delivery. J Control Release 58: 233-245. (Pubitemid 29112894)
19. Graves, R. A., Freeman, T., Mandal, T. K. (2007). In vitro dissolution method for evaluation of buprenorphine in situ gel formulation: atechnical note. AAPS PharmSciTech 8: E62.
20. Higuchi, T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52: 1145-1149.
21. Ito, F., Fujimori, H., Makino, K. (2007). Incorporation of water-soluble drugs in PLGA microspheres. Coll Surf B Biointerf 54: 173-178. (Pubitemid 46136929)
22. Jain, R. A. (2000). The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21: 2475-2490.
23. Jain, R. A., Rhodes, C. T., Railkar, A. M., Malick, A. W., Shah, N. H. (2000a). Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. J Microencapsul 17: 343-362. (Pubitemid 30235007)
24. Jain, R. A., Rhodes, C. T., Railkar, A. M., Malick, A. W., Shah, N. H. (2000b). Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Eur J Pharm Biopharm 50: 257-262.
25. Jiang, G., Woo, B. H., Kang, F., Singh, J., DeLuca, P. P. (2002). Assessment of protein release kinetics, stability, and protein polymer interaction of lysozyme encapsulated poly(D,L-lactideco-glycolide) microspheres. J Control Release 79: 137-145. (Pubitemid 34164167)
26. Kranz, H., Yilmaz, E., Brazeau, G. A., Bodmeier, R. (2008). In vitroand in vivo drug release from a novel in situ forming drug deliverysystem. Pharm Res 25: 1347-1354. (Pubitemid 351624356)
27. Lacout, J.-L., Freche, M., Goncalves, S., Rodriguez, F. (2005). Method for preparing a calcium phosphate pasty material for injection. US Patent 6923989.
28. Leroux, L., Hatim, Z., Freche, M., Lacout, J. L. (1999). Effects of various adjuvants (lactic acid, glycerol, and chitosan) on the injectability of a calcium phosphate cement. Bone 25: 31S-34S. (Pubitemid 29333175)
29. Li, F., Li, S., Ghzaoui, A. E., Nouailhas, H., Zhuo, R. (2007). Synthesis and gelation properties of PEG-PLA-PEG triblock copolymers obtained by coupling monohydroxylated PEG-PLA with adipoyl chloride. Langmuir 23: 2778-2783. (Pubitemid 46383700)
30. Lu, Y., Yu, Y., Tang, X. (2007). Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. J Pharm Sci 96: 3252-3262.
31. Luan, X., Bodmeier, R. (2006). Influence of the poly(lactide-coglycolide) type on the leuprolide release from in situ forming microparticle systems. J Control Release 110: 266-272. (Pubitemid 41827479)
32. Matschke, C., Isele, U., van Hoogevest, P., Fahr, A. (2002). Sustainedrelease injectables formed in situ and their potential use for veterinary products. J Control Release 85: 1-15. (Pubitemid 35449450)
33. McHugh, A. J. (2005). The role of polymer membrane formation in sustained release drug delivery systems. J Control Release 109: 211-221. (Pubitemid 41737265)
34. McHugh, A. J., Desnoyer J. R. (2007). Injectable system for controlled drug delivery.
35. Moncalvo, D., Friedel, L. (2010). A viscosity correction factor for shearthinning liquid flows in safety valves. J Loss Prevention Process Ind 23: 289-293.
36. Nasr, M., Mansour, S., Mortada, N. D., El Shamy, A. A. (2008). Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. AAPS PharmSciTech 9: 154-162.
37. Packhaeuser, C. B., Schnieders, J., Oster, C. G., Kissel, T. (2004). In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 58: 445-455. (Pubitemid 39037247)
38. Paradkar, A., Maheshwari, M., Tyagi, A. K., Chauhan, B., Kadam, S. S. (2003). Preparation and characterization of flurbiprofen beads by melt solidification technique. AAPS PharmSciTech 4: E65.
39. Patel, R. B., Carlson, A. N., Solorio, L., Exner, A. A. (2010a). Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems. J Biomed Mater Res A 94: 476-484.
40. Patel, R. B., Solorio, L., Wu, H., Krupka, T., Exner, A. A. (2010b). Effect of injection site on in situ implant formation and drug release in vivo. J Control Release 147: 350-358.
41. Paul, S., Egbert, J. E., Walsh, A. W., Hoey, M. F. (1998). Pressure measurements during injection of corticosteroids. Med Biol Eng Comput 36: 729-733.
42. Peppas, N. A., Sahlin, J. J. (1989). A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm 57: 169-172. (Pubitemid 20011841)
43. Perova, T. S., Christensen, D. H., Rasmussen, U., Vij, J. K., Nielsen, O. F. (1998). Far-infrared spectra of highly viscous liquids: glycerol and triacetin (glycerol triacetate). Vibrational Spectroscopy 18: 149-156.
44. Pluta, J., Karolewicz, B. (2006). In vitro studies of the properties of thermosensitive systems prepared on Pluronic F-127 as vehicles for methotrexate for delivery to solid tumours. Polim Med 36: 37-53.
45. Raman, C., McHugh, A. J. (2005). A model for drug release from fast phase inverting injectable solutions. J Control Release 102: 145-157. (Pubitemid 40093781)
46. Ramchandani, M., Robinson, D. (1998). In vitro and in vivo release of ciprofloxacin from PLGA 50: 50 implants. J Control Release 54: 167-175. (Pubitemid 28342695)
47. Ribeiro, H. M., Morais, J. A., Eccleston, G. M. (2004). Structure and rheology of semisolid o/w creams containing cetyl alcohol/nonionic surfactant mixed emulsifier and different polymers. Int JCosmet Sci 26: 47-59. (Pubitemid 38501316)
48. Ritger, P. L., Peppas, N. A. (1987). A simple equation for description of solute release II. fickian and anomalous release from swellable devices. J Control Release 5: 37-42. (Pubitemid 17106644)
49. Rungseevijitprapa, W., Bodmeier, R. (2009). Injectability of biodegradable in situ forming microparticle systems (ISM). Eur J Pharm Sci 36: 524-531.
50. Sepulveda, E., Kildsig, D. O., Ghaly, E. S. (2003). Relationship between internal phase volume and emulsion stability: the cetyl alcohol/stearyl alcohol system. Pharm Dev Technol 8: 263-275. (Pubitemid 36900233)
51. SIDS. (2002). Triacetin. UNEP. Available at: http://www.inchem.org/ documents/sids/sids/102761.pdf. Accessed on March 11, 2011.
52. Smaby, N., Johanson, M. E., Baker, B., Kenney, D. E., Murray, W. M., Hentz, V. R. (2004). Identification of key pinch forces required to complete functional tasks. J Rehabil Res Dev 41: 215-224.
53. Solorio, L., Babin, B. M., Patel, R. B., Mach, J., Azar, N., Exner, A. A. (2010). Noninvasive characterization of in situ forming implants using diagnostic ultrasound. J Control Release 143: 183-190.
54. Suzuki, Y., Nishimura, Y., Tanihara, M., Suzuki, K., Nakamura, T., Shimizu, Y., et al. (1998). Evaluation of a novel alginate gel dressing: cytotoxicity to fibroblasts in vitro and foreign-body reaction in pig skin in vivo. J Biomed Mater Res 39: 317-322. (Pubitemid 28060366)
55. Vernon, B. L., Fusaro, F., Borden, B., Roy, K. H. (2004). Partitioncontrolled progesterone release from waterborne, in situ-gelling materials. Int J Pharm 274: 191-200. (Pubitemid 38457018)
56. Vlad, S., Oprea, S. (2001). Evlauation of rheological behaviour of some thermoplastic polyurethane solutions. Eur Pol J 37: 2461-2464. (Pubitemid 32903610)
57. Yoon, J. J., Chung, H. J., Park, T. G. (2007). Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor. J Biomed Mater Res A 83: 597-605. (Pubitemid 350086285)
58. You, Y., Lee, S. J., Min, B.-M., Park, W. H. (2006). Effect of solution properties on nanofibrous structure of electrospun poly(lactic-coglycolic acid). J Appl Polym Sci 99: 1214-1221.